Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Int J Pharm ; 660: 124254, 2024 May 23.
Article in English | MEDLINE | ID: mdl-38795934

ABSTRACT

Cancer vaccines can be utilized in combination with checkpoint inhibitors to optimally stimulate the anti-tumor immune response. Uptake of vaccine antigen by antigen presenting cells (APCs) is a prerequisite for T cell priming, but often relies on non-specific mechanisms. Here, we have developed a novel vaccination strategy consisting of cancer antigen-containing liposomes conjugated with CD169- or DC-SIGN-specific nanobodies (single domain antibodies) to achieve specific uptake by APCs. Our studies demonstrate efficient nanobody liposome uptake by human and murine CD169+ and DC-SIGN+ APCs in vitro and in vivo when compared to control liposomes or liposomes with natural ligands for CD169 and DC-SIGN. Uptake of CD169 nanobody liposomes resulted in increased T cell activation by human APCs and stimulated naive T cell priming in mouse models. In conclusion, while nanobody liposomes have previously been utilized to direct drugs to tumors, here we show that nanobody liposomes can be applied as vaccination strategy that can be extended to other receptors on APCs in order to elicit a potent immune response against tumor antigens.

2.
Mutagenesis ; 2024 Apr 12.
Article in English | MEDLINE | ID: mdl-38606763

ABSTRACT

Pleiotropic variants (i.e., genetic polymorphisms influencing more than one phenotype) are often associated with cancer risk. A scan of pleiotropic variants was successfully conducted ten years ago in relation to pancreatic ductal adenocarcinoma susceptibility. However, in the last decade, genetic association studies performed on several human traits have greatly increased the number of known pleiotropic variants. Based on the hypothesis that variants already associated with a least one trait have a higher probability of association with other traits, 61,052 variants reported to be associated by at least one genome wide association study (GWAS) with at least one human trait were tested in the present study consisting of two phases (discovery and validation), comprising a total of 16,055 pancreatic ductal adenocarcinoma (PDAC) cases and 212,149 controls. The meta-analysis of the two phases showed two loci (10q21.1-rs4948550 (P=6.52×10-5) and 7q36.3-rs288762 (P=3.03×10-5) potentially associated with PDAC risk. 10q21.1-rs4948550 shows a high degree of pleiotropy and it is also associated with colorectal cancer risk while 7q36.3-rs288762 is situated 28,558 base pairs upstream of the Sonic Hedgehog (SHH) gene, which is involved in the cell differentiation process and PDAC etiopathogenesis. In conclusion, none of the single nucleotide polymorphisms (SNPs) showed a formally statistically significant association after correction for multiple testing. However, given their pleiotropic nature and association with various human traits including colorectal cancer, the two SNPs showing the best associations with PDAC risk merit further investigation through fine mapping and ad hoc functional studies.

3.
Ann Oncol ; 29(2): 472-483, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29244072

ABSTRACT

Background: Smoking has been associated with colorectal cancer (CRC) incidence and mortality in previous studies and might also be associated with prognosis after CRC diagnosis. However, current evidence on smoking in association with CRC prognosis is limited. Patients and methods: For this individual patient data meta-analysis, sociodemographic and smoking behavior information of 12 414 incident CRC patients (median age at diagnosis: 64.3 years), recruited within 14 prospective cohort studies among previously cancer-free adults, was collected at baseline and harmonized across studies. Vital status and causes of death were collected for a mean follow-up time of 5.1 years following cancer diagnosis. Associations of smoking behavior with overall and CRC-specific survival were evaluated using Cox regression and standard meta-analysis methodology. Results: A total of 5229 participants died, 3194 from CRC. Cox regression revealed significant associations between former [hazard ratio (HR) = 1.12; 95 % confidence interval (CI) = 1.04-1.20] and current smoking (HR = 1.29; 95% CI = 1.04-1.60) and poorer overall survival compared with never smoking. Compared with current smoking, smoking cessation was associated with improved overall (HR<10 years = 0.78; 95% CI = 0.69-0.88; HR≥10 years = 0.78; 95% CI = 0.63-0.97) and CRC-specific survival (HR≥10 years = 0.76; 95% CI = 0.67-0.85). Conclusion: In this large meta-analysis including primary data of incident CRC patients from 14 prospective cohort studies on the association between smoking and CRC prognosis, former and current smoking were associated with poorer CRC prognosis compared with never smoking. Smoking cessation was associated with improved survival when compared with current smokers. Future studies should further quantify the benefits of nonsmoking, both for cancer prevention and for improving survival among CRC patients, in particular also in terms of treatment response.


Subject(s)
Colorectal Neoplasms/mortality , Smoking/adverse effects , Aged , Female , Humans , Male , Middle Aged , Prognosis , Smoking Cessation
5.
Eur J Clin Nutr ; 71(4): 512-518, 2017 04.
Article in English | MEDLINE | ID: mdl-28120853

ABSTRACT

BACKGROUND/OBJECTIVES: The role of long-term alcohol consumption for the risk of developing ulcerative colitis (UC) and Crohn's disease (CD) is unclear. For the first time, to prospectively assess the role of pre-disease alcohol consumption on the risk of developing UC or CD. SUBJECTS/METHODS: Nested within the European Prospective Investigation into Cancer and Nutrition (EPIC-IBD), incident UC and CD cases and matched controls where included. At recruitment, participants completed validated food frequency and lifestyle questionnaires. Alcohol consumption was classified as either: non-use, former, light (⩽0.5 and 1 drink per week), below the recommended limits (BRL) (⩽1 and 2 drinks per day), moderate (⩽2.5 and 5 drinks per day), or heavy use (>2.5 and >5 drinks per day) for women and men, respectively; and was expressed as consumption at enrolment and during lifetime. Conditional logistic regression was applied adjusting for smoking and education, taking light users as the reference. RESULTS: Out of 262 451 participants in six countries, 198 UC incident cases/792 controls and 84 CD cases/336 controls were included. At enrolment, 8%/27%/32%/23%/11% UC cases and 7%/29%/40%/19%/5% CD cases were: non-users, light, BRL, moderate and heavy users, respectively. The corresponding figures for lifetime non-use, former, light, BRL, moderate and heavy use were: 3%/5%/23%/44%/19%/6% and 5%/2%/25%/44%/23%/1% for UC and CD cases, respectively. There were no associations between any categories of alcohol consumption and risk of UC or CD in the unadjusted and adjusted odds ratios. CONCLUSION: There was no evidence of associations between alcohol use and the odds of developing either UC or CD.


Subject(s)
Alcohol Drinking/adverse effects , Colitis, Ulcerative/etiology , Crohn Disease/etiology , Adult , Aged , Case-Control Studies , Colitis, Ulcerative/epidemiology , Crohn Disease/epidemiology , Europe/epidemiology , Female , Humans , Incidence , Logistic Models , Male , Middle Aged , Odds Ratio , Prospective Studies , Risk Factors , Young Adult
6.
Animal ; 10(3): 539-46, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26355556

ABSTRACT

Ractopamine hydrochloride (RH) alters protein metabolism and improves growth performance in Bos taurus cattle with high carcass fat. Our objective was to evaluate the effects of RH, dietary CP and RH×CP interaction on performance, blood metabolites, carcass characteristics and meat quality of young Nellore bulls. A total of 48 bulls were randomly assigned to four treatments in a 2×2 factorial arrangement. The factors were two levels of dietary CP (100% and 120% of metabolizable protein requirement, defined as CP100 and CP120, respectively), and two levels of RH (0 and 300 mg/animal·per day). Treated animal received RH for the final 35 days before slaughter. Animals were weighed at the beginning of the feedlot period (day 63), at the beginning of ractopamine supplementation (day 0), after 18 days of supplementation (day 18) and before slaughter (day 34). Animals were slaughtered and hot carcass weights recorded. After chilling, carcass data was collected and longissimus samples were obtained for determination of meat quality. The 9-11th rib section was removed for carcass composition analysis. Supplementation with RH increased ADG independently of dietary CP. There was a RH×CP interaction on dry matter intake (DMI), where RH reduced DMI at CP120, with no effect at CP100. Ractopamine improved feed efficiency, without RH×CP interaction. Ractopamine had no effect on plasma creatinine and urea concentration. Greater dietary CP tended to increase blood urea, and there was a RH×CP interaction for plasma total protein. Ractopamine supplementation increased plasma total protein at CP120, and had no effect at CP100. Ractopamine also decreased plasma glucose concentration at CP100, but had no effect at CP120. Ractopamine increased alkaline phosphatase activity at CP120 and had no effect at CP100. There was a tendency for RH to increase longissimus muscle area, independently of dietary CP. Ractopamine did not alter fat thickness; however, fat thickness was reduced by greater CP in the diet. Supplementation with RH decreased meat shear force, but only at day 0 of aging, having no effect after 7, 14 or 21 days. Greater dietary protein increased meat shear force after 0 and 7 days of aging, with no effect after 14 or 21 days. These results demonstrate for the first time the efficacy of ractopamine supplementation to improve gain and feed efficiency of intact Bos indicus males, with relatively low carcass fat content. Ractopamine effects were not further improved by increasing dietary protein content above requirements.


Subject(s)
Diet/veterinary , Meat/standards , Phenethylamines/pharmacology , Adrenergic beta-Agonists/pharmacology , Animals , Blood Urea Nitrogen , Body Composition/physiology , Cattle , Dietary Proteins/administration & dosage , Dietary Supplements , Male , Nutritional Requirements , Phenotype , Urea
7.
J Anim Sci ; 92(12): 5622-34, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25414108

ABSTRACT

Fiber digestibility is an important factor regulating DMI in ruminants. Additionally, the ensiling process can also affect digestibility and chemical composition of the forage. The objective of this study was to investigate effects of sugarcane NDF digestibility (NDFD) and conservation method on intake, rumen kinetics, and the ruminal ecosystem of steers. Eight ruminally cannulated Nellore steers (275±22 kg BW) were used in a replicated 4×4 Latin square design with a 2×2 factorial arrangement of treatments. Two sugarcane genotypes divergent for stalk NDFD were used: IAC86-2480 with high NDFD and SP91-1049 with low NDFD. Experimental diets were formulated with 40% sugarcane, either freshly cut or as silage, and 60% concentrate on a DM basis. Each experimental period lasted for 14 d, with the last 4 d used for determination of intake, ruminal evacuation, and ruminal fluid collection. The effect of fiber digestibility on DM and NDF intake was dependent on the forage conservation method (P=0.01). High NDFD increased (P<0.01) DMI only when sugarcane was offered as silage, having no effect (P=0.41) on DMI when offered as freshly cut. Conservation method had no effect on total ruminal mass, with only a tendency (P<0.10) for greater NDF and indigestible NDF ruminal mass in steers fed the low-NDFD genotype. The NDF turnover and passage rates were greater (P<0.05) for the genotype with high NDFD but only when offered as silage. Liquid turnover rate in the rumen was greater (P=0.02) for diets containing silage, with no effect of genotype (P=0.87). There was no effect of NDFD genotype on ruminal pH (P=0.77); however, diets containing sugarcane as silage increased (P<0.01) ruminal pH. Total concentration of short chain fatty acids (P=0.05) and proportions of propionate (P=0.01) were greater for diets containing fresh sugarcane. Diets with fresh sugarcane increased the ruminal population of Streptococcus bovis (P<0.01) and Ruminococcus albus (P=0.03). The relative population of R. albus was also greater (P=0.04) for diets containing the sugarcane genotype with high NDFD. Feeding diets containing the sugarcane genotype with high NDFD increased Fibrobacter succinogenes population but only when sugarcane was fed as freshly cut (P=0.02). Using sugarcane genotypes with high NDFD can increase intake and benefit fiber-degrading bacteria in the rumen.


Subject(s)
Appetite Regulation/drug effects , Cattle/growth & development , Diet/veterinary , Dietary Fiber/pharmacology , Digestion/drug effects , Rumen/metabolism , Ammonia/metabolism , Animal Feed/analysis , Animals , Fatty Acids, Volatile/metabolism , Hydrogen-Ion Concentration , In Vitro Techniques , Male , Random Allocation , Rumen/microbiology , Ruminococcus/isolation & purification , Saccharum/metabolism , Silage/analysis , Streptococcus bovis/isolation & purification
8.
Curr Microbiol ; 69(3): 245-51, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24715050

ABSTRACT

The Helicobacter pylori extra gastric reservoir is probably the oral cavity. In order to evaluate the presence of this bacterium in patients with periodontitis and suspicious microbial cultures, saliva was collected from these and non-periodontitis subjects. PCRs targeting 16S rRNA gene and a 860 bp specific region were performed, and digested with the restriction enzyme DdeI. We observed that the PCR-RFLP approach augments the accuracy from 26.2 % (16/61), found in the PCR-based results, to 42.6 % (26/61), which is an excellent indicator for the establishment of this low-cost procedure as a diagnostic/confirmatory method for H. pylori evaluation.


Subject(s)
Carrier State/diagnosis , Helicobacter pylori/isolation & purification , Molecular Diagnostic Techniques/methods , Mouth/microbiology , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , DNA, Bacterial/genetics , Helicobacter Infections/diagnosis , Helicobacter pylori/genetics , Humans , Mass Screening/methods , RNA, Ribosomal, 16S/genetics , Sensitivity and Specificity
9.
Aliment Pharmacol Ther ; 39(8): 834-42, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24611981

ABSTRACT

BACKGROUND: There are plausible mechanisms for how dietary docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, could prevent Crohn's disease (CD). AIM: To conduct a prospective study to investigate the association between increased intake of DHA and risk of CD. METHODS: Overall, 229 702 participants were recruited from nine European centres between 1991 and 1998. At recruitment, dietary intakes of DHA and fatty acids were measured using validated food frequency questionnaires. The cohort was monitored through to June 2004 to identify participants who developed incident CD. In a nested case-control analysis, each case was matched with four controls; odds ratios (ORs) were calculated for quintiles of DHA intake, adjusted for total energy intake, smoking, other dietary fatty acids, dietary vitamin D and body mass index. RESULTS: Seventy-three participants developed incident CD. All higher quintiles of DHA intake were inversely associated with development of CD; the highest quintile had the greatest effect size (OR = 0.07; 95% CI = 0.02-0.81). The OR trend across quintiles of DHA was 0.54 (95% CI = 0.30-0.99, Ptrend  = 0.04). Including BMI in the multivariate analysis, due to its correlation with dietary fat showed similar associations. There were no associations with the other dietary fatty acids studied. CONCLUSION: There were inverse associations, with a biological gradient between increasing dietary docosahexaenoic acid intakes and incident Crohn's disease. Further studies in other populations should measure docosahexaenoic acid to determine if the association is consistent and the hypothesis tested in randomised controlled trials of purely docosahexaenoic acid supplementation.


Subject(s)
Crohn Disease/prevention & control , Dietary Fats/administration & dosage , Docosahexaenoic Acids/therapeutic use , Adult , Aged , Case-Control Studies , Crohn Disease/epidemiology , Docosahexaenoic Acids/administration & dosage , Energy Intake , Female , Humans , Male , Middle Aged , Multivariate Analysis , Prospective Studies , Risk Factors , Surveys and Questionnaires
10.
Clin Genet ; 84(3): 244-50, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23170986

ABSTRACT

The MSH2 c.388_389del mutation has occasionally been described in Lynch families worldwide. At the Portuguese Oncology Institute in Porto, Portugal, we have identified 16 seemingly unrelated families with this germline mutation. To evaluate if this alteration is a founder or a recurrent mutation we performed haplotype analysis in the 16 Portuguese index cases and 55 relatives, as well as in four index cases and 13 relatives reported from Germany, Scotland, England, and Argentina. In the Portuguese families we observed a shared haplotype of approximately 10 Mb and all were originated from the north of Portugal. These results suggest that this alteration is a founder mutation in Portugal with a relatively recent origin. In the reported families outside Portugal with this mutation different haplotype backgrounds were observed, supporting the hypothesis that it occurred de novo on multiple occasions. We also conclude that the high proportion of families with the MSH2 c.388_389del mutation indicates that screening for this alteration as a first step may be cost-effective in the genetic testing of Lynch syndrome suspects of Portuguese ancestry, especially those originating from the north of Portugal.


Subject(s)
Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Founder Effect , MutS Homolog 2 Protein/genetics , Sequence Deletion , Argentina , Base Sequence , England , Germ-Line Mutation , Germany , Haplotypes , Humans , Microsatellite Repeats , Nucleotide Motifs , Polymorphism, Single Nucleotide , Portugal
11.
Eur J Clin Nutr ; 66(12): 1303-8, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23149980

ABSTRACT

BACKGROUND/OBJECTIVES: Heavy alcohol drinking is a risk factor of colorectal cancer (CRC), but little is known on the effect of polymorphisms in the alcohol-metabolizing enzymes, alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) on the alcohol-related risk of CRC in Caucasian populations. SUBJECTS/METHODS: A nested case-control study (1269 cases matched to 2107 controls by sex, age, study centre and date of blood collection) was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC) to evaluate the impact of rs1229984 (ADH1B), rs1573496 (ADH7) and rs441 (ALDH2) polymorphisms on CRC risk. Using the wild-type variant of each polymorphism as reference category, CRC risk estimates were calculated using conditional logistic regression, with adjustment for matching factors. RESULTS: Individuals carrying one copy of the rs1229984(A) (ADH1B) allele (fast metabolizers) showed an average daily alcohol intake of 4.3 g per day lower than subjects with two copies of the rs1229984(G) allele (slow metabolizers) (P(diff)<0.01). None of the polymorphisms was associated with risk of CRC or cancers of the colon or rectum. Heavy alcohol intake was more strongly associated with CRC risk among carriers of the rs1573496(C) allele, with odds ratio equal to 2.13 (95% confidence interval: 1.26-3.59) compared with wild-type subjects with low alcohol consumption (P(interaction)=0.07). CONCLUSIONS: The rs1229984(A) (ADH1B) allele was associated with a reduction in alcohol consumption. The rs1229984 (ADH1B), rs1573496 (ADH7) and rs441 (ALDH2) polymorphisms were not associated with CRC risk overall in Western-European populations. However, the relationship between alcohol and CRC risk might be modulated by the rs1573496 (ADH7) polymorphism.


Subject(s)
Alcohol Dehydrogenase/genetics , Alcohol Drinking/genetics , Aldehyde Dehydrogenase/genetics , Colorectal Neoplasms/genetics , Ethanol/metabolism , Polymorphism, Genetic , White People/genetics , Aged , Alcohol Drinking/metabolism , Alleles , Case-Control Studies , Europe , Female , Humans , Logistic Models , Male , Middle Aged , Odds Ratio , Prospective Studies , Risk Assessment , Risk Factors
12.
Eur J Clin Nutr ; 65(10): 1079-87, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21559044

ABSTRACT

BACKGROUND/OBJECTIVES: The relation between lifetime use of alcohol and measures of abdominal and general adiposity is unknown. SUBJECTS/METHODS: Among 99,381 men and 158,796 women of the European Prospective Investigation into Cancer and Nutrition (EPIC) study, means of waist circumference (WC), waist-to-hip-ratio (WHR) and body mass index (BMI), and odds ratios (OR) for a larger WC than predicted for a given BMI (WClp=positive residuals of gender specific linear regression of BMI on WC) across categories of average lifetime use of alcohol (total, from wine and from beer) were calculated, all adjusted for socio-demographic, lifestyle and health factors. RESULTS: WC, WHR and BMI in men using lifetime ≤6 g/d alcohol were 95.1 cm, 0.942 and 27.3 kg/m(2), and 96.2 cm, 0.961 and 28.3 kg/m(2) when using >96 g/d. WC and WHR in women was 83.2 cm and 0.813 for ≤6 g/d, and 84.6 cm and 0.830 for >60 g/d, whereas BMI deviated only slightly with the lowest BMI (26.7 kg/m(2)) observed for >6-24 g/d. Compared with ≤6 g/d, OR for a WClp in both genders increased steadily across categories of alcohol use (up to 1.40 (95% confidence interval 1.32, 1.49) in men using >60 g/d and 1.63 (1.54, 1.73) in women using >24 g/d), though increase was higher for alcohol from beer than from wine (P for difference between beer and wine<0.001 (men) and=0.002 (women)). CONCLUSION: Lifetime alcohol use is positively related to abdominal and general adiposity in men, possibly following the male weight gain pattern; in women, it is positively related only to abdominal adiposity. In this context, beer may contribute additionally to abdominal adiposity.


Subject(s)
Abdominal Fat/drug effects , Adiposity/drug effects , Alcohol Drinking/adverse effects , Obesity/epidemiology , Adult , Aged , Beer/adverse effects , Body Composition , Body Mass Index , Female , Humans , Life Style , Male , Middle Aged , Obesity/etiology , Prospective Studies , Risk Factors , Waist Circumference , Waist-Hip Ratio , Weight Gain , White People , Wine/adverse effects
13.
Cancer Epidemiol ; 34(6): 696-701, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20829145

ABSTRACT

INTRODUCTION: Until now, studies examining the relationship between socioeconomic status and pancreatic cancer incidence have been inconclusive. AIM: To prospectively investigate to what extent pancreatic cancer incidence varies according to educational level within the European Prospective Investigation into Cancer and Nutrition (EPIC) study. METHODS: In the EPIC study, socioeconomic status at baseline was measured using the highest level of education attained. Hazard ratios by educational level and a summary index, the relative indices of inequality (RII), were estimated using Cox regression models stratified by age, gender, and center and adjusted for known risk factors. In addition, we conducted separate analyses by age, gender and geographical region. RESULTS: Within the source population of 407, 944 individuals at baseline, 490 first incident primary pancreatic adenocarcinoma cases were identified in 9 European countries. The crude difference in risk of pancreatic cancer according to level of education was small and not statistically significant (RII=1.14, 95% CI 0.80-1.62). Adjustment for known risk factors reduced the inequality estimates to only a small extent. In addition, no statistically significant associations were observed for age groups (adjusted RII(≤ 60 years)=0.85, 95% CI 0.44-1.64, adjusted RII(>60 years)=1.18, 95% CI 0.73-1.90), gender (adjusted RII(male)=1.20, 95% CI 0.68-2.10, adjusted RII(female)=0.96, 95% CI 0.56-1.62) or geographical region (adjusted RII(Northern Europe)=1.14, 95% CI 0.81-1.61, adjusted RII(Middle Europe)=1.72, 95% CI 0.93-3.19, adjusted RII(Southern Europe)=0.75, 95% CI 0.32-1.80). CONCLUSION: Despite large educational inequalities in many risk factors within the EPIC study, we found no evidence for an association between educational level and the risk of developing pancreatic cancer in this European cohort.


Subject(s)
Adenocarcinoma/epidemiology , Pancreatic Neoplasms/epidemiology , Adenocarcinoma/pathology , Adult , Age Factors , Aged , Cohort Studies , Educational Status , Europe/epidemiology , Female , Humans , Incidence , Male , Middle Aged , Pancreatic Neoplasms/pathology , Proportional Hazards Models , Prospective Studies , Risk Factors , Sex Factors , Socioeconomic Factors
14.
Clin Transl Oncol ; 9(11): 731-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18055328

ABSTRACT

INTRODUCTION: The aim of the present study was to assess if the presence of survivin mRNA in exfoliated cells present in urine samples can be a reliable marker of the presence of bladder tumour and recurrence. MATERIALS AND METHODS: Urine samples from 30 patients with superficial urothelial cell carcinomas (UCC) were collected prior to transurethral resection (TUR) of the tumour and in the first routine follow-up, three months after TUR. Detection of survivin mRNA was performed by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: No correlation was observed between survivin detection and the clinicopathological variables analysed, nevertheless, when patients were grouped into low-grade (G1) and high-grade (G2+G3) tumours, statistically significant differences were found between both groups (p=0.04). When we analysed the results of survivin detection and urinary cytology together, we observed that informative cases rose from 27.8% to 44.4%. Also, Kaplan-Meier curves for patients with negative cytology in the first followup, categorised according to survivin detection, revealed that survivin mRNA positive cases recurred earlier than negative ones. CONCLUSIONS: From our results we can conclude that detection of survivin expression can be a reliable tumour marker, but more studies are needed to clarify the potential of survivin to predict recurrences. These results showed that survivin detection in combination with conventional urinary cytology can be a useful tool to increase the sensitivity in detecting the presence of a recurrence after TUR.


Subject(s)
Biomarkers, Tumor/urine , Carcinoma, Transitional Cell/urine , Microtubule-Associated Proteins/genetics , Neoplasm Proteins/genetics , Neoplasm Recurrence, Local/diagnosis , RNA, Messenger/urine , RNA, Neoplasm/urine , Urinary Bladder Neoplasms/urine , Adult , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/genetics , Carcinoma, Transitional Cell/surgery , Female , Gene Expression Regulation, Neoplastic , Humans , Inhibitor of Apoptosis Proteins , Male , Middle Aged , Neoplasm Recurrence, Local/urine , Prognosis , RNA, Messenger/genetics , RNA, Neoplasm/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Survival Rate , Survivin , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/surgery , Urothelium/metabolism
15.
Clin. transl. oncol. (Print) ; 9(11): 731-736, nov. 2007. tab, ilus
Article in English | IBECS | ID: ibc-123383

ABSTRACT

INTRODUCTION: The aim of the present study was to assess if the presence of survivin mRNA in exfoliated cells present in urine samples can be a reliable marker of the presence of bladder tumour and recurrence. MATERIALS AND METHODS: Urine samples from 30 patients with superficial urothelial cell carcinomas (UCC) were collected prior to transurethral resection (TUR) of the tumour and in the first routine follow-up, three months after TUR. Detection of survivin mRNA was performed by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: No correlation was observed between survivin detection and the clinicopathological variables analysed, nevertheless, when patients were grouped into low-grade (G1) and high-grade (G2+G3) tumours, statistically significant differences were found between both groups (p=0.04). When we analysed the results of survivin detection and urinary cytology together, we observed that informative cases rose from 27.8% to 44.4%. Also, Kaplan-Meier curves for patients with negative cytology in the first followup, categorised according to survivin detection, revealed that survivin mRNA positive cases recurred earlier than negative ones. CONCLUSIONS: From our results we can conclude that detection of survivin expression can be a reliable tumour marker, but more studies are needed to clarify the potential of survivin to predict recurrences. These results showed that survivin detection in combination with conventional urinary cytology can be a useful tool to increase the sensitivity in detecting the presence of a recurrence after TUR (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/urine , Microtubule-Associated Proteins , Microtubule-Associated Proteins/genetics , Neoplasm Recurrence, Local/diagnosis , Neoplasm Proteins/genetics , RNA, Messenger/genetics , RNA, Messenger/urine , RNA, Ribosomal/urine , Biomarkers/urine , Urinary Bladder Neoplasms/urine , Carcinoma, Transitional Cell/genetics , Carcinoma, Transitional Cell/surgery , Gene Expression Regulation, Neoplastic , Inhibitor of Apoptosis Proteins , Neoplasm Recurrence, Local/urine , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/surgery , Sensitivity and Specificity
16.
Br J Cancer ; 95(6): 752-6, 2006 Sep 18.
Article in English | MEDLINE | ID: mdl-16940983

ABSTRACT

Germline MLH1 and MSH2 mutations are scarce in young colorectal cancer patients with negative family history of the disease. To evaluate the contribution of germline MSH6 mutations to early-onset colorectal cancer, we have analysed peripheral blood of 38 patients diagnosed with this disease before 45 years of age and who presented no family history of hereditary nonpolyposis colorectal cancer-related cancers. Blood samples from 108 healthy volunteers were analysed for those genetic alterations suspected to affect the function of MSH6. Of the seven (18.4%) MSH6 alterations found, we have identified three novel germline mutations, one 8 bp deletion leading to a truncated protein and two missense mutations resulting in the substitution of amino acids belonging to different polarity groups. High-frequency microsatellite instability was found in the patient with the MSH6 deletion, but not in the other 27 carcinomas analysed. No MLH1 promoter methylation was detected in tumour tissue. Our findings suggest that germline MSH6 mutations contribute to a subset of early-onset colorectal cancer. Further studies are warranted to understand the genetic and environmental factors responsible for the variable penetration of MSH6 germline mutations, as well as to identify other causes of early-onset colorectal cancer.


Subject(s)
Colorectal Neoplasms/genetics , DNA-Binding Proteins/genetics , Germ-Line Mutation , Adolescent , Adult , Age of Onset , Colorectal Neoplasms/diagnosis , Exons , Female , Humans , Introns , Male , Middle Aged , Pedigree
17.
BMJ ; 330(7486): 277, 2005 Feb 05.
Article in English | MEDLINE | ID: mdl-15681570

ABSTRACT

OBJECTIVES: To investigate the association between environmental tobacco smoke, plasma cotinine concentration, and respiratory cancer or death. DESIGN: Nested case-control study within the European prospective investigation into cancer and nutrition (EPIC). PARTICIPANTS: 303,020 people from the EPIC cohort (total 500,000) who had never smoked or who had stopped smoking for at least 10 years, 123,479 of whom provided information on exposure to environmental tobacco smoke. Cases were people who developed respiratory cancers or died from respiratory conditions. Controls were matched for sex, age (plus or minus 5 years), smoking status, country of recruitment, and time elapsed since recruitment. MAIN OUTCOME MEASURES: Newly diagnosed cancer of lung, pharynx, and larynx; deaths from chronic obstructive pulmonary disease or emphysema. Plasma cotinine concentration was measured in 1574 people. RESULTS: Over seven years of follow up, 97 people had newly diagnosed lung cancer, 20 had upper respiratory cancers (pharynx, larynx), and 14 died from chronic obstructive pulmonary disease or emphysema. In the whole cohort exposure to environmental tobacco smoke was associated with increased risks (hazard ratio 1.30, 95% confidence interval 0.87 to 1.95, for all respiratory diseases; 1.34, 0.85 to 2.13, for lung cancer alone). Higher results were found in the nested case-control study (odds ratio 1.70, 1.02 to 2.82, for respiratory diseases; 1.76, 0.96 to 3.23, for lung cancer alone). Odds ratios were consistently higher in former smokers than in those who had never smoked; the association was limited to exposure related to work. Cotinine concentration was clearly associated with self reported exposure (3.30, 2.07 to 5.23, for detectable/non-detectable cotinine), but it was not associated with the risk of respiratory diseases or lung cancer. Frequent exposure to environmental tobacco smoke during childhood was associated with lung cancer in adulthood (hazard ratio 3.63, 1.19 to 11.11, for daily exposure for many hours). CONCLUSIONS: This large prospective study, in which the smoking status was supported by cotinine measurements, confirms that environmental tobacco smoke is a risk factor for lung cancer and other respiratory diseases, particularly in ex-smokers.


Subject(s)
Laryngeal Neoplasms/etiology , Lung Neoplasms/etiology , Pharyngeal Neoplasms/etiology , Pulmonary Disease, Chronic Obstructive/etiology , Tobacco Smoke Pollution/adverse effects , Adult , Aged , Biomarkers/blood , Cotinine/blood , Epidemiologic Methods , Female , Humans , Laryngeal Neoplasms/blood , Laryngeal Neoplasms/mortality , Lung Neoplasms/blood , Lung Neoplasms/mortality , Male , Middle Aged , Pharyngeal Neoplasms/blood , Pharyngeal Neoplasms/mortality , Pulmonary Disease, Chronic Obstructive/blood , Pulmonary Disease, Chronic Obstructive/mortality , Smoking/adverse effects , Smoking/blood
18.
Br J Cancer ; 90(3): 632-4, 2004 Feb 09.
Article in English | MEDLINE | ID: mdl-14760376

ABSTRACT

The ratio of deoxycholic acid to chenodeoxycholic acid in the serum of 62 men was inversely related to body mass index and to saturated fat intake after adjustment for body mass index, smoking, and age conversely, this ratio was associated positively with the intake of fibre from grains.


Subject(s)
Body Mass Index , Chenodeoxycholic Acid/blood , Colorectal Neoplasms/epidemiology , Colorectal Neoplasms/etiology , Deoxycholic Acid/blood , Smoking/adverse effects , Adult , Age Factors , Dietary Fats , Epidemiologic Studies , Humans , Male , Middle Aged , Risk Factors
19.
Behav Res Ther ; 41(7): 777-93, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12781245

ABSTRACT

In this article, it is suggested that cross-cultural assessment of emotional disturbances would benefit from the consideration of cultural differences in the modal, and normative emotions. A summary of the research literature on cultural differences in emotions, in particular in antecedent events, subjective feeling, appraisal, and behavior is provided. Cultural differences in emotions are understood functionally, such that the most prevalent emotional phenomena in a culture are those that fit and reinforce the distinct cultural models (i.e. goals and practices) of self and relationship. It is argued that a culture-sensitive approach to emotional disturbances would entail the assessment of emotional phenomena that are dysfunctional to the cultural models of self and relationship.


Subject(s)
Affective Symptoms/ethnology , Cross-Cultural Comparison , Emotions , Affective Symptoms/psychology , Cultural Diversity , Humans , Outcome Assessment, Health Care/methods , Research , Social Behavior
20.
J Pers Soc Psychol ; 80(1): 68-74, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11195892

ABSTRACT

A theory of cultural differences in emotions was tested in a questionnaire study. Hypotheses about the differences between emotion in individualist and collectivist contexts covered different components of emotion: concerns and appraisals, action readiness, social sharing, and belief changes. The questionnaire focused on 6 types of events that were rated as similar in meaning across cultures. Participants were 86 Dutch individualist respondents and 171 Surinamese and Turkish collectivist respondents living in the Netherlands. As compared with emotions in individualist cultures, emotions in collectivist cultures (a) were more grounded in assessments of social worth and of shifts in relative social worth, (b) were to a large extent taken to reflect reality rather than the inner world of the individual, and (c) belonged to the self-other relationship rather than being confined to the subjectivity of the self.


Subject(s)
Cultural Characteristics , Emotions , Individuality , Social Identification , Adult , Cross-Cultural Comparison , Female , Humans , Male , Models, Psychological , Netherlands , Sampling Studies , Suriname/ethnology , Surveys and Questionnaires , Turkey/ethnology
SELECTION OF CITATIONS
SEARCH DETAIL
...